Immutep
IMMP
6 hedge funds and large institutions have $354K invested in Immutep in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
2,489% more capital inflows, than outflows
Capital inflows: $259K | Capital outflows: $10K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
0.15% more ownership
Funds ownership: 0.05% → 0.2% (+0.15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$135K |
| 2 |
Boothbay Fund Management
New York
|
+$123K |
| 3 |
Thompson Davis & Co
Richmond,
Virginia
|
+$872 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10K |
IMMP Hedge Fund Activity: Q2 2018 in Review
6 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Immutep (IMMP) for Q2 2018, worth a combined $354K — up 428% from $67K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMMP positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $135K. The largest seller was UBS Group, exiting entirely with an estimated $10K sold.
- 6 institutional investors held Immutep (IMMP) as of Q2 2018, up from 4 in Q1 2018.
- Funds reported $354K of Immutep stock for Q2 2018, up 428% quarter-over-quarter.
- 3 funds opened new Immutep positions in Q2 2018 and 1 closed out, a net change of +2 holders.
- The largest Immutep buyer in Q2 2018 was Morgan Stanley, an estimated $135K added.
- The largest Immutep seller in Q2 2018 was UBS Group, an estimated $10K sold.
Based on aggregated 13F filings for Q2 2018.